ManageEngine RecoveryManager Plus
RecoveryManager Plus keeps widening its backup coverage across the Microsoft identity estate.
A side-by-side editorial comparison of AgencyAnalytics and DoseFinding — release velocity, themes, recent moves, and the top alternatives to consider.
AgencyAnalytics is turning its assistant into scheduled agency staff work, not a chat box.
The release cadence is weekly and heavily weighted toward AgencyAI. Skills landed in early August as named, runnable agency tasks; scheduling followed, letting those requests run on a cadence and post results into the client's conversation. Around them sit portfolio-management improvements — client tags, report share history, advanced metric filtering — and a consolidated Data tab feeding the assistant's context.
New stewardship at openpharma, then two releases adding the methods MCP-Mod was missing
DoseFinding implements MCP-Mod and related dose-response methodology for clinical trial design and analysis. In 2024 it changed hands — Marius Thomas took over as maintainer, Novartis was recorded as copyright holder and funder, and the package moved to the openpharma GitHub organisation with roxygen documentation and a proper NEWS file. The two releases since have added substantive methodology: model averaging for dose-response fitting in 1.3-1, and conditional and predictive power for interim analyses in 1.4-1.
The release cadence is weekly and heavily weighted toward AgencyAI. Skills landed in early August as named, runnable agency tasks; scheduling followed, letting those requests run on a cadence and post results into the client's conversation. Around them sit portfolio-management improvements — client tags, report share history, advanced metric filtering — and a consolidated Data tab feeding the assistant's context.
Every recent release either gives AgencyAI more to read or more autonomy in when it runs. The Data tab consolidation, the AI Tracker add-on for AI search visibility, and now scheduling all point the same way: the platform is being positioned to produce the recurring client deliverables an agency would otherwise assign to a junior analyst.
Expect scheduled AgencyAI output to gain delivery paths beyond conversation history — into reports or client-facing sends — given the existing report scheduling and share infrastructure.
DoseFinding implements MCP-Mod and related dose-response methodology for clinical trial design and analysis. In 2024 it changed hands — Marius Thomas took over as maintainer, Novartis was recorded as copyright holder and funder, and the package moved to the openpharma GitHub organisation with roxygen documentation and a proper NEWS file. The two releases since have added substantive methodology: model averaging for dose-response fitting in 1.3-1, and conditional and predictive power for interim analyses in 1.4-1.
The pattern before the handover was maintenance — R-devel compliance, a bug fix, a link. After it, each release carries a named methodological addition with an acknowledged contributor, plus documentation to match: a longitudinal analysis vignette shipped alongside the interim power work. Housekeeping continues underneath, mostly clearing deprecated ggplot2 interfaces, aes_string in one release and qplot in the next.
Given the last two releases each added one method with a supporting vignette, expect the next to follow the same shape. Both additions so far extend the package beyond fixed dose-response fitting, so adaptive and interim methodology is the more likely direction.
Other Analytics products tracked by Sparkpulse, ranked by recent ship velocity. Each card links to a full editorial trajectory and lets you pivot into a head-to-head comparison with either AgencyAnalytics or DoseFinding.
RecoveryManager Plus keeps widening its backup coverage across the Microsoft identity estate.
Omni ships weekly, and almost every week the headline item is an AI feature.
silx settles into maintenance a release after its PySide6 migration
Plotly is turning its cloud into a metered compute platform with an enterprise on-ramp.
aniread stops asking you to know which tracker wrote the file
Rho's release machinery finally produced a stable build — and it shipped no new product.
See all AgencyAnalytics alternatives → · See all DoseFinding alternatives →
Latest ship moves from both products, interleaved chronologically. ⚡ = editorial spark.
They serve adjacent needs but don't currently overlap on shipped themes. AgencyAnalytics is currently shipping more aggressively (velocity 6.3 vs 0.0), with 1 editorial sparks in the last 30 days against 0. See the at-a-glance table above for a side-by-side breakdown of velocity, recent sparks, and editorial themes.
Sparkpulse doesn't pick a winner — we score release velocity, not feature parity. AgencyAnalytics is currently shipping more aggressively (velocity 6.3 vs 0.0), with 1 editorial sparks in the last 30 days against 0. For your specific use case, the alternatives sections above list other Analytics products to evaluate alongside.
Top AgencyAnalytics alternatives in Analytics are ranked by recent ship velocity. Browse the "AgencyAnalytics alternatives" section above for the current picks, or visit /alternatives/agencyanalytics for the full list with editorial commentary on each.
Top DoseFinding alternatives in Analytics are ranked by recent ship velocity. Browse the "DoseFinding alternatives" section above for the current picks, or visit /alternatives/dosefinding for the full list with editorial commentary on each.